Tevogen Long Term Debt vs Common Stock Analysis

TVGNW Stock

0.05 0 5.63%

Tevogen Bio financial indicator trend analysis is much more than just breaking down Tevogen Bio Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tevogen Bio Holdings is a good investment. Please check the relationship between Tevogen Bio Long Term Debt and its Common Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Common Stock

Long Term Debt vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tevogen Bio Holdings Long Term Debt account and Common Stock. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Tevogen Bio's Long Term Debt and Common Stock is 0.55. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Common Stock in the same time period over historical financial statements of Tevogen Bio Holdings, assuming nothing else is changed. The correlation between historical values of Tevogen Bio's Long Term Debt and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Tevogen Bio Holdings are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Long Term Debt i.e., Tevogen Bio's Long Term Debt and Common Stock go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Tevogen Bio Holdings has held for over one year. Long-term debt appears on Tevogen Bio Holdings balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Tevogen Bio Holdings balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Common Stock

Most indicators from Tevogen Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tevogen Bio Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Tevogen Bio's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to about 10.2 K in 2024, whereas Selling General Administrative is likely to drop slightly above 1.8 M in 2024.

	2010	2022	2023	2024 (projected)
Reconciled Depreciation	9.4K	230.8K	265.4K	278.7K
Total Operating Expenses	4.6M	953.1K	2.3M	2.1M

Reconciled Depreciation Total Operating Expenses

Tevogen Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue
Total Assets		0.52	-0.7	-0.16	1.0	0.74	0.77	0.9	-0.26	-0.56	1.0	0.56	0.53	-0.56	-0.07	-0.55	0.8	-0.56	-0.63	1.0	0.6	-0.57	1.0	-0.43	1.0	-0.07
Short Long Term Debt Total	0.52		0.25	-0.93	0.5	-0.18	0.95	0.79	-0.86	0.42	0.5	-0.41	-0.41	0.42	-0.86	0.42	0.93	0.41	0.32	0.57	-0.32	0.4	0.5	0.55	0.5	-0.85
Other Current Liab	-0.7	0.25		-0.59	-0.72	-1.0	-0.07	-0.36	-0.43	0.98	-0.72	-0.99	-0.94	0.98	-0.65	0.98	-0.12	0.99	0.99	-0.65	-0.95	0.99	-0.72	0.95	-0.72	-0.64
Total Current Liabilities	-0.16	-0.93	-0.59		-0.14	0.54	-0.76	-0.52	0.87	-0.73	-0.14	0.72	0.69	-0.73	0.96	-0.73	-0.73	-0.72	-0.65	-0.22	0.63	-0.72	-0.14	-0.82	-0.14	0.94
Total Stockholder Equity	1.0	0.5	-0.72	-0.14		0.76	0.75	0.89	-0.24	-0.58	1.0	0.58	0.55	-0.58	-0.04	-0.57	0.78	-0.58	-0.65	1.0	0.62	-0.59	1.0	-0.45	1.0	-0.04
Property Plant And Equipment Net	0.74	-0.18	-1.0	0.54	0.76		0.14	0.42	0.39	-0.97	0.76	0.97	0.93	-0.97	0.61	-0.97	0.18	-0.97	-0.98	0.7	0.95	-0.97	0.76	-0.92	0.76	0.6
Net Debt	0.77	0.95	-0.07	-0.76	0.75	0.14		0.93	-0.75	0.11	0.75	-0.1	-0.11	0.11	-0.67	0.12	1.0	0.1	0.01	0.8	-0.02	0.09	0.75	0.26	0.75	-0.66
Retained Earnings	0.9	0.79	-0.36	-0.52	0.89	0.42	0.93		-0.45	-0.19	0.89	0.2	0.24	-0.19	-0.37	-0.18	0.94	-0.2	-0.25	0.92	0.33	-0.2	0.89	-0.05	0.89	-0.34
Accounts Payable	-0.26	-0.86	-0.43	0.87	-0.24	0.39	-0.75	-0.45		-0.56	-0.24	0.56	0.67	-0.56	0.95	-0.55	-0.73	-0.56	-0.42	-0.31	0.61	-0.55	-0.24	-0.66	-0.24	0.96
Cash	-0.56	0.42	0.98	-0.73	-0.58	-0.97	0.11	-0.19	-0.56		-0.58	-1.0	-0.96	1.0	-0.77	1.0	0.06	1.0	0.99	-0.51	-0.95	1.0	-0.58	0.99	-0.58	-0.75
Non Current Assets Total	1.0	0.5	-0.72	-0.14	1.0	0.76	0.75	0.89	-0.24	-0.58		0.58	0.55	-0.58	-0.04	-0.57	0.78	-0.58	-0.65	1.0	0.62	-0.59	1.0	-0.45	1.0	-0.04
Non Currrent Assets Other	0.56	-0.41	-0.99	0.72	0.58	0.97	-0.1	0.2	0.56	-1.0	0.58		0.96	-1.0	0.76	-1.0	-0.05	-1.0	-0.99	0.51	0.95	-1.0	0.59	-0.99	0.59	0.75
Long Term Debt	0.53	-0.41	-0.94	0.69	0.55	0.93	-0.11	0.24	0.67	-0.96	0.55	0.96		-0.96	0.81	-0.95	-0.07	-0.96	-0.9	0.48	1.0	-0.96	0.55	-0.95	0.55	0.81
Cash And Short Term Investments	-0.56	0.42	0.98	-0.73	-0.58	-0.97	0.11	-0.19	-0.56	1.0	-0.58	-1.0	-0.96		-0.77	1.0	0.06	1.0	0.99	-0.51	-0.95	1.0	-0.58	0.99	-0.58	-0.75
Common Stock Shares Outstanding	-0.07	-0.86	-0.65	0.96	-0.04	0.61	-0.67	-0.37	0.95	-0.77	-0.04	0.76	0.81	-0.77		-0.76	-0.64	-0.76	-0.66	-0.13	0.75	-0.76	-0.04	-0.85	-0.04	1.0
Non Current Liabilities Total	-0.55	0.42	0.98	-0.73	-0.57	-0.97	0.12	-0.18	-0.55	1.0	-0.57	-1.0	-0.95	1.0	-0.76		0.07	1.0	0.99	-0.5	-0.94	1.0	-0.57	0.99	-0.57	-0.75
Other Current Assets	0.8	0.93	-0.12	-0.73	0.78	0.18	1.0	0.94	-0.73	0.06	0.78	-0.05	-0.07	0.06	-0.64	0.07		0.05	-0.04	0.83	0.02	0.05	0.78	0.21	0.78	-0.63
Other Stockholder Equity	-0.56	0.41	0.99	-0.72	-0.58	-0.97	0.1	-0.2	-0.56	1.0	-0.58	-1.0	-0.96	1.0	-0.76	1.0	0.05		0.99	-0.51	-0.95	1.0	-0.59	0.99	-0.59	-0.75
Total Liab	-0.63	0.32	0.99	-0.65	-0.65	-0.98	0.01	-0.25	-0.42	0.99	-0.65	-0.99	-0.9	0.99	-0.66	0.99	-0.04	0.99		-0.58	-0.91	0.99	-0.65	0.96	-0.65	-0.64
Net Invested Capital	1.0	0.57	-0.65	-0.22	1.0	0.7	0.8	0.92	-0.31	-0.51	1.0	0.51	0.48	-0.51	-0.13	-0.5	0.83	-0.51	-0.58		0.55	-0.52	1.0	-0.37	1.0	-0.12
Property Plant And Equipment Gross	0.6	-0.32	-0.95	0.63	0.62	0.95	-0.02	0.33	0.61	-0.95	0.62	0.95	1.0	-0.95	0.75	-0.94	0.02	-0.95	-0.91	0.55		-0.95	0.62	-0.93	0.62	0.76
Total Current Assets	-0.57	0.4	0.99	-0.72	-0.59	-0.97	0.09	-0.2	-0.55	1.0	-0.59	-1.0	-0.96	1.0	-0.76	1.0	0.05	1.0	0.99	-0.52	-0.95		-0.59	0.99	-0.59	-0.75
Capital Stock	1.0	0.5	-0.72	-0.14	1.0	0.76	0.75	0.89	-0.24	-0.58	1.0	0.59	0.55	-0.58	-0.04	-0.57	0.78	-0.59	-0.65	1.0	0.62	-0.59		-0.45	1.0	-0.04
Net Working Capital	-0.43	0.55	0.95	-0.82	-0.45	-0.92	0.26	-0.05	-0.66	0.99	-0.45	-0.99	-0.95	0.99	-0.85	0.99	0.21	0.99	0.96	-0.37	-0.93	0.99	-0.45		-0.45	-0.84
Common Stock	1.0	0.5	-0.72	-0.14	1.0	0.76	0.75	0.89	-0.24	-0.58	1.0	0.59	0.55	-0.58	-0.04	-0.57	0.78	-0.59	-0.65	1.0	0.62	-0.59	1.0	-0.45		-0.04
Current Deferred Revenue	-0.07	-0.85	-0.64	0.94	-0.04	0.6	-0.66	-0.34	0.96	-0.75	-0.04	0.75	0.81	-0.75	1.0	-0.75	-0.63	-0.75	-0.64	-0.12	0.76	-0.75	-0.04	-0.84	-0.04

Click cells to compare fundamentals

Tevogen Bio Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Tevogen Stock Analysis

When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tevogen Long Term Debt vs Common Stock Analysis

Long Term Debt vs Common Stock

Long Term Debt vs Common Stock Correlation Analysis

Correlation Coefficient

Long Term Debt

Common Stock

Tevogen Bio fundamental ratios Correlations

Tevogen Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Tevogen Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Capital Stock	+ 1.0	Total Assets
Common Stock	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Stockholder Equity

Total Current Assets	- 1.0	Non Currrent Assets Other
Other Stockholder Equity	- 1.0	Non Currrent Assets Other
Non Current Liabilities Total	- 1.0	Non Currrent Assets Other
Cash And Short Term Investments	- 1.0	Non Currrent Assets Other
Non Currrent Assets Other	- 1.0	Cash
Property Plant And Equipment Net	- 1.0	Other Current Liab